107 Views
Sunday Poster Session
Category: Functional Bowel Disease
Will Takakura, MD
Cedars-Sinai Medical Center - MAST Program
Los Angeles, CA, United States
Detectable CH4 (n=18) | Undetectable CH4 (n=25) | p-value | |
Age | 43.5±20.2 | 55.0±15.9 | 0.30 |
Gender (Male) | 7 (38.9%) | 5 (20.0%) | 0.30 |
Anticholinergic | 5 (27.8%) | 6 (24.0%) | >0.99 |
Dementia | 0 (0%) | 1 (4.0%) | >0.99 |
Parkinsons | 0 (0%) | 0 (0%) | >0.99 |
Depression | 4 (22.2%) | 11 (44.0%) | 0.20 |
SLE | 0 (0%) | 2 (8.0%) | 0.50 |
Diabetes | 1 (5.56%) | 2 (8.0%) | >0.99 |
Hyperthyroidism | 0 (0%) | 0 (0%) | >0.99 |
Hypothyroidism | 4 (22.2%) | 3 (12.0%) | 0.43 |
HIV | 0 (0%) | 1 (4%) | >0.99 |
Esophagectomy of Fundoplication | 8 (44.4%) | 7 (28.0%) | 0.34 |